Outcome of treatment with fludarabine versus fludarabine and cyclophosphamide in chronic lymphocytic leukemia (CLL) is adversely impacted by high risk genetic features: Results from ECOG 2997.

被引：5

作者：

Grever, MR

Lucas, DM

Dewald, GW

Neuberg, DS

Flinn, IW

Appelbaum, FR

Larson, RA

Tallman, MS

Gribben, JG

Byrd, JC

机构：

[1] Ohio State Univ, Columbus, OH 43210 USA

[2] Mayo Clin, Rochester, MN USA

[3] Dana Farber Canc Inst, Boston, MA 02115 USA

[4] Johns Hopkins, Baltimore, MD USA

[5] Northwestern Univ, Chicago, IL 60611 USA

[6] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA

[7] Univ Chicago, Chicago, IL 60637 USA

来源：

关键词：

D O I：

10.1182/blood.V104.11.3487.3487

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

3487

引用

页码：950A / 951A

页数：2